You are here:

telmisartan (Micardis)


In the absence of a submission from the holder of the marketing authorisation

telmisartan (Micardis), is not recommended for use within NHSScotland for use in cardiovascular prevention (to reduce cardiovascular morbidity in patients with manifest atherothrombotic cardiovascular disease history of coronary heart disease, stroke, or peripheral arterial disease) or type 2 diabetes mellitus with documented target organ damage.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: telmisartan (Micardis)
SMC Drug ID: 631/10
Manufacturer: Boehringer Ingelheim Ltd
Indication: For use in cardiovascular prevention or type 2 diabetes mellitus
BNF Category:
Sub Category: 2.5 Hypertension and heart failure
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 9 May 2010